Anticoagulation in syncardia total artificial heart recipients: anti-factor Xa or activated partial thromboplastin time?

MLA

Derek R. Robinson, et al. “Anticoagulation in Syncardia Total Artificial Heart Recipients: Anti-Factor Xa or Activated Partial Thromboplastin Time?” Interactive Cardiovascular and Thoracic Surgery, vol. 34, no. 2, Mar. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0c3fc5c730a07655779bca37d016f802&authtype=sso&custid=ns315887.

APA

Derek R. Robinson, Christopher T. Bowles, Andre R. Simon, Binu Raj, & Maria Monteagudo-Vela. (2021). Anticoagulation in syncardia total artificial heart recipients: anti-factor Xa or activated partial thromboplastin time? Interactive Cardiovascular and Thoracic Surgery, 34(2).

Chicago

Derek R. Robinson, Christopher T. Bowles, Andre R. Simon, Binu Raj, and Maria Monteagudo-Vela. 2021. “Anticoagulation in Syncardia Total Artificial Heart Recipients: Anti-Factor Xa or Activated Partial Thromboplastin Time?” Interactive Cardiovascular and Thoracic Surgery 34 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0c3fc5c730a07655779bca37d016f802&authtype=sso&custid=ns315887.